• Company
  • News
  • Investors
  • Contacts
  • Careers
polypeptide-logopolypeptide-logologo-mobilepolypeptide-logo
  • Services
    • GMP Compliance
    • Pre-GMP development
    • Production
    • Quality Assurance
    • Quality control
    • Regulatory Support
  • Commercial Manufacturing
    • Commercial products at PolyPeptide
    • Late stage development
    • Process development and optimization
    • Capacity and Capabilities
  • Custom R&D
    • Custom Research Grade Peptides
    • Radiolabeled peptide
  • Generic peptides
  • Oligos
  • Services
    • GMP Compliance
    • Pre-GMP development
    • Production
    • Quality Assurance
    • Quality control
    • Regulatory Support
  • Commercial Manufacturing
    • Commercial products at PolyPeptide
    • Late stage development
    • Process development and optimization
    • Capacity and Capabilities
  • Custom R&D
    • Custom Research Grade Peptides
    • Radiolabeled peptide
  • Generic peptides
  • Oligos
✕
  • Home
  • News
  • Media releases
  • PolyPeptide signs scientific collaboration agreement

PolyPeptide signs scientific collaboration agreement

31 October 2023
Media releases

Strasbourg, 31 October 2023 – PolyPeptide today announced the signing of a collaboration agreement with the Peptide Sciences Laboratory of the University of KwaZulu-Natal (UKZN) in Durban, South Africa. Professor Fernando Albericio and Professor Beatriz G. de la Torre will support one of PolyPeptide’s innovation projects to improve the sustainability of peptide manufacturing.

Consistent with its strategic aspiration to lead in innovation, PolyPeptide’s global innovation and technology team continues to work on a portfolio of projects to improve the sustainability of peptide manufacturing. This includes efforts to reduce, recycle, replace, or even avoid altogether hazardous solvents, which is particularly relevant against the backdrop of increasing customer demand and growing manufacturing volumes.

PolyPeptide has now signed a collaboration agreement with the University of KwaZulu-Natal (UKZN) in Durban, South Africa, where Fernando Albericio and Beatriz G. de la Torre work as research professors with the Peptide Sciences Laboratory. The purpose of the agreement is to ensure their scientific and academic support for one of PolyPeptide’s innovation projects in solid-phase synthesis.

Olivier Ludemann-Hombourger, Director Global Innovation and Technology: «With some of our technology projects, we challenge the status quo in peptide manufacturing. If successful, we will be able to significantly increase throughput and productivity, coupled with the optimization of solvent consumption and the reduction of the environmental footprint. At PolyPeptide it is our firm ambition that our customers get their products not only faster but also greener.»

[…]

Download PDF (English)

Download PDF (German)

Back to news

Related posts

9 April 2025

PolyPeptide announces results of the annual General Meeting 2025


Read more
18 March 2025

PolyPeptide publishes invitation to the annual General Meeting 2025


Read more
13 January 2025

Cytovance Biologics and PolyPeptide Announce Collaboration for Microbial and Mammalian-Expressed Peptide Drugs


Read more

Polypeptide Group

INFO

COMPANY
LEADERSHIP
CONTACTS
CAREERS

NEWS

LATEST NEWS
SIGN UP FOR NEWS
EVENTS

SOCIALS

LINKEDIN
YOUTUBE
© Confidentiality 2025 PolyPeptide Group • Cookie Policy • Sitemap • Privacy policy
    • Company
    • News
    • Investors
    • Contacts
    • Careers
    Language 1
    Language 2
    Language 3
    Privacy on this site

    We only use necessary cookies to help make a website usable by enabling basic functions such as page navigation and access to secure areas of the website. The website cannot function properly without these cookies. By clicking 'Accept', you consent to the use of necessary cookies on our website. Read our privacy policy for further details. You will find it in the footer of every page you visit

    Cookie policy
    Piwik PROPowered by